1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow NTRK Family Gene Mutation: new trials by email Literature Review of NTRK Family Gene Mutation trials Research Report on NTRK Family Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetic Testing in Guiding Treatment for Patients With Brain Metastases Abemaciclib, PI3K Inhibitor paxalisib, Entrectinib - CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain | Phase 2 | Active not recruiting | Alliance for Clinical Trials in Oncology | 50 | 2019-10-17 | 2026-10-30 |
Brain Neoplasms (1) · Neoplasm Metastasis (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
abemaciclib (1) · adagrasib (1) · entrectinib (1)
Alliance for Clinical Trials in Oncology (1)
United States (1)
U10CA180821 (1)